Analyst Ratings for CME Group Inc. Cl A (CME)

Updated: 2017-07-28

CME Group Inc. Cl A (NASDAQ:CME) was awarded an average rating of Overweight from investment analysts following the stock. CME had previously received a consensus rating of Overweight a month ago.

16 analysts issued ratings on the stock, where 9 gave CME a buy rating, 0 issued an overweight rating, 6 gave a hold rating, 1 issued an underweight rating, and 0 issued a sell rating. Today, there are 1 more analysts optimistic about the company future as compared with 90 days ago. Over the same time period, there has been an increase of 0 in the number of analysts with a negative outlook on the stock.

CME was given price targets by several analysts. The most optimistic analyst gave a price target of 140, implying potential capital gains of 15.3 percent. The most pessimistic analyst gave a price target of 106, implying a possible loss of -12.7 percent. Many analysts are not unbiased in their coverage of stocks, including price targets and stock ratings, so care must be taken in interpreting numbers released by them.

In the last 30 days, analysts have changed their quarterly earnings estimates downwards by an average of -1.23 percent. The average change in earnings estimates over the last 90 days is -3.23 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -0.51 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 2 analysts have revised their quarterly estimates upwards in the past 30 days, while 5 analysts revised their estimates downwards. During this time, 4 analysts made positive revisions in their estimates for this fiscal year's earnings, while 4 analysts made negative revisions to their fiscal year's estimates.

CME has an estimated earnings growth rate of 4.99 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. A lower PEG ratio is favorable, because people typically see that as an indicator of higher growth relative to stock price. Many investors consider PEG ratios between 0 and 1 as preferrable, but many choose to perform ratio comparisons with other companies in the industry. The PEG ratio of CME is 5.27.

In the last 52-weeks, CME has achieved a high of 127.96 and a low of 98.95. The current market price is above the trailing year's low by 22.71 percent, and 5.11 percent below the high. CME has a price/earnings ratio of 26.3. Investors typically compare the P/E ratio to a company's peers in the industry. The CME value stock report compares CME to some of its peers using value stock charts. The market cap of CME is $41.24 billion. CME will post this quarters earnings in days, on 0000-00-00.